BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ramachandran R, Bech P, Murphy KG, Dhillo WS, Meeran KM, Chapman RS, Caplin M, Ghatei MA, Bloom SR, Martin NM. Improved diagnostic accuracy for neuroendocrine neoplasms using two chromogranin A assays. Clin Endocrinol (Oxf) 2012;76:831-6. [PMID: 22175276 DOI: 10.1111/j.1365-2265.2011.04319.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Lewis MA, Yao JC. Molecular pathology and genetics of gastrointestinal neuroendocrine tumours: . Current Opinion in Endocrinology & Diabetes and Obesity 2014;21:22-7. [DOI: 10.1097/med.0000000000000033] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
2 Glinicki P, Kapuścińska R, Jeske W. Improved diagnostic accuracy for neuroendocrine neoplasms using two chromogranin A assays: the importance of protein matrix effects. Clin Endocrinol 2013;79:295-6. [DOI: 10.1111/cen.12088] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
3 van der Knaap RHP, Kwekkeboom DJ, Ramakers CRB, de Rijke YB. Evaluation of a new immunoassay for chromogranin A measurement on the Kryptor system. Pract Lab Med 2015;1:5-11. [PMID: 28932793 DOI: 10.1016/j.plabm.2015.03.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
4 Boot C, Toole B, Harris S, Tetlow L, Wassif WS. A UK national audit of the laboratory investigation of phaeochromocytoma and paraganglioma. Ann Clin Biochem 2021;:45632211046759. [PMID: 34605294 DOI: 10.1177/00045632211046759] [Reference Citation Analysis]
5 Weber DM, Yang JY, Goldman SM, Clarke NJ, Taylor SW, McPhaul MJ. Antibody-Free Quantification of Serum Chromogranin A by Targeted Mass Spectrometry. Clin Chem 2021;67:1618-27. [PMID: 34718463 DOI: 10.1093/clinchem/hvab191] [Reference Citation Analysis]
6 Butler OL, Mekhael MM, Ahmed A, Cuthbertson DJ, Pritchard DM. Frequency and Causes of False-Positive Elevated Plasma Concentrations of Fasting Gut Hormones in a Specialist Neuroendocrine Tumor Center. Front Endocrinol (Lausanne) 2020;11:606264. [PMID: 33391185 DOI: 10.3389/fendo.2020.606264] [Reference Citation Analysis]
7 Dobson R, Burgess MI, Banks M, Pritchard DM, Vora J, Valle JW, Wong C, Chadwick C, George K, Keevil B, Adaway J, Ardill JE, Anthoney A, Hofmann U, Poston GJ, Cuthbertson DJ. The association of a panel of biomarkers with the presence and severity of carcinoid heart disease: a cross-sectional study. PLoS One 2013;8:e73679. [PMID: 24069222 DOI: 10.1371/journal.pone.0073679] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.7] [Reference Citation Analysis]
8 Basuroy R, Sarker D, Quaglia A, Srirajaskanthan R, Ramage J. Personalized medicine for gastroenteropancreatic neuroendocrine tumors: a distant dream? International Journal of Endocrine Oncology 2015;2:201-15. [DOI: 10.2217/ije.15.9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
9 Eissa N, Hussein H, Hendy GN, Bernstein CN, Ghia JE. Chromogranin-A and its derived peptides and their pharmacological effects during intestinal inflammation. Biochem Pharmacol 2018;152:315-26. [PMID: 29656116 DOI: 10.1016/j.bcp.2018.04.009] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
10 Gruson D, Lepoutre T, Smits F. Chromogranin-A Levels Measured with Automated Immunoassay. Int J Biol Markers 2015;30:132-5. [DOI: 10.5301/jbm.5000096] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
11 Bech P, Martin N, Ramachandran R, Bloom S. The biochemical utility of chromogranin A, chromogranin B and cocaine- and amphetamine-regulated transcript for neuroendocrine neoplasia. Ann Clin Biochem 2014;51:8-21. [DOI: 10.1177/0004563213489670] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
12 Modlin IM, Drozdov I, Kidd M. The identification of gut neuroendocrine tumor disease by multiple synchronous transcript analysis in blood. PLoS One. 2013;8:e63364. [PMID: 23691035 DOI: 10.1371/journal.pone.0063364] [Cited by in Crossref: 85] [Cited by in F6Publishing: 82] [Article Influence: 9.4] [Reference Citation Analysis]
13 Rossi RE, Garcia-Hernandez J, Meyer T, Thirlwell C, Watkins J, Martin NG, Caplin ME, Toumpanakis C. Chromogranin A as a predictor of radiological disease progression in neuroendocrine tumours. Ann Transl Med. 2015;3:118. [PMID: 26207246 DOI: 10.3978/j.issn.2305-5839.2015.04.23] [Cited by in F6Publishing: 5] [Reference Citation Analysis]